Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
18 12 2019
Historique:
received: 02 12 2018
revised: 23 08 2019
accepted: 20 11 2019
entrez: 20 12 2019
pubmed: 20 12 2019
medline: 15 9 2020
Statut: ppublish

Résumé

Loss of function in tumor suppressor genes is commonly associated with the onset/progression of cancer and treatment resistance. The

Identifiants

pubmed: 31852795
pii: 11/523/eaaw1565
doi: 10.1126/scitranslmed.aaw1565
pmc: PMC7024563
mid: NIHMS1555938
pii:
doi:

Substances chimiques

RNA, Messenger 0
Tumor Suppressor Protein p53 0
Everolimus 9HW64Q8G6G
TOR Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : P30 CA006516
Pays : United States
Organisme : NINDS NIH HHS
ID : P30 NS072030
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA200900
Pays : United States
Organisme : NCI NIH HHS
ID : R25 CA174650
Pays : United States

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

J Biol Chem. 2006 Nov 17;281(46):34870-9
pubmed: 16990266
Biomaterials. 2009 Apr;30(12):2180-98
pubmed: 19200596
Nat Commun. 2015 Oct 27;6:8620
pubmed: 26503418
Clin Cancer Res. 2016 Feb 15;22(4):868-76
pubmed: 26459177
Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):E1941-E1950
pubmed: 28202722
J Biol Chem. 2017 Dec 1;292(48):19607
pubmed: 29196570
Cancer Res. 2013 Jan 1;73(1):3-7
pubmed: 23288916
Transl Oncol. 2010 Apr;3(2):65-79
pubmed: 20360931
Nano Lett. 2015 Dec 9;15(12):8099-107
pubmed: 26529392
Cell. 2012 Apr 13;149(2):274-93
pubmed: 22500797
Cancer Res. 2015 Sep 15;75(18):3842-52
pubmed: 26294215
Clin Cancer Res. 2010 Jan 1;16(1):240-8
pubmed: 20008839
Curr Opin Mol Ther. 2007 Oct;9(5):423-31
pubmed: 17932806
Nature. 2007 Feb 8;445(7128):661-5
pubmed: 17251932
Nat Med. 2002 Mar;8(3):282-8
pubmed: 11875500
Nature. 2017 Oct 26;550(7677):481-486
pubmed: 29045389
J Cell Biol. 1997 Jul 28;138(2):449-69
pubmed: 9230085
Mol Ther. 2018 Mar 7;26(3):801-813
pubmed: 29433939
Gastroenterology. 2008 Dec;135(6):1972-83, 1983.e1-11
pubmed: 18929564
Nat Biotechnol. 2004 Jan;22(1):3-4
pubmed: 14704685
Nat Biotechnol. 2008 Oct;26(10):1057-9
pubmed: 18846056
Nano Lett. 2012 Jul 11;12(7):3587-91
pubmed: 22716029
Science. 2004 Feb 6;303(5659):844-8
pubmed: 14704432
Nature. 2014 Jul 31;511(7511):543-50
pubmed: 25079552
Cell Rep. 2017 Dec 19;21(12):3548-3558
pubmed: 29262333
Cell. 2017 Jun 15;169(7):1327-1341.e23
pubmed: 28622513
Cancer Res. 2006 Feb 15;66(4):2233-41
pubmed: 16489026
Nat Rev Cancer. 2017 Jan;17(1):20-37
pubmed: 27834398
JAMA. 2014 Jul 2;312(1):57-67
pubmed: 25058218
Nat Biotechnol. 2011 Feb;29(2):154-7
pubmed: 21217696
Nat Biomed Eng. 2018 Nov;2(11):850-864
pubmed: 31015614
Clin Cancer Res. 2012 Oct 1;18(19):5278-89
pubmed: 22879389
Cancer Res. 2018 Jul 15;78(14):4045-4058
pubmed: 29764863
Angew Chem Int Ed Engl. 2015 Aug 3;54(32):9218-23
pubmed: 26119453
Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12469-74
pubmed: 20616057
Mol Cell Biol. 2015 Nov 23;36(3):438-51
pubmed: 26598601
Trends Cell Biol. 2000 Sep;10(9):369-77
pubmed: 10932094
Cell Death Differ. 2018 Jan;25(1):133-143
pubmed: 29125602
Sci Transl Med. 2011 Jan 5;3(64):64rv1
pubmed: 21209413
Cancer Res. 2000 Apr 15;60(8):2190-6
pubmed: 10786683
Ann Oncol. 2014 Feb;25(2):409-15
pubmed: 24368400
Clin Cancer Res. 2010 Dec 1;16(23):5900-7
pubmed: 21045083
Onco Targets Ther. 2014 Oct 21;7:1901-9
pubmed: 25364261
Nat Rev Genet. 2014 Aug;15(8):541-55
pubmed: 25022906
Nat Rev Clin Oncol. 2010 Apr;7(4):209-19
pubmed: 20234352
Nano Res. 2018 Oct;11(10):5281-5309
pubmed: 31007865
Autophagy. 2008 Aug;4(6):810-4
pubmed: 18604159
Elife. 2018 May 01;7:
pubmed: 29714688
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Nature. 2009 Apr 30;458(7242):1127-30
pubmed: 19407794
Cancer Res. 2014 Sep 15;74(18):5127-38
pubmed: 25085248
Nat Nanotechnol. 2012 Oct;7(10):623-9
pubmed: 23042546
Br J Cancer. 2019 Feb;120(3):286-293
pubmed: 30585255
Development. 2000 Nov;127(22):4949-58
pubmed: 11044408
Biomaterials. 2011 Aug;32(22):5223-30
pubmed: 21514660
Eur J Cancer. 2003 Sep;39(13):1828-34
pubmed: 12932659
Gut. 2005 Sep;54(9):1318-9
pubmed: 15879012
Mol Ther. 2016 Sep;24(9):1697-706
pubmed: 27357628
Nat Cell Biol. 2008 Jun;10(6):676-87
pubmed: 18454141
Target Oncol. 2011 Mar;6(1):17-27
pubmed: 21547705
Vaccine. 2012 Jun 22;30(30):4414-8
pubmed: 22546329
Antioxid Redox Signal. 2014 Mar 1;20(7):1086-97
pubmed: 23373831
Nat Genet. 2015 May;47(5):505-511
pubmed: 25822088
Mol Ther Nucleic Acids. 2017 Jun 16;7:350-365
pubmed: 28624211
Cell. 2012 Jun 8;149(6):1269-83
pubmed: 22682249
Cell Res. 2017 Mar;27(3):440-443
pubmed: 28117345
Mol Cancer. 2013 Mar 05;12:17
pubmed: 23497256
J Control Release. 2011 May 30;152(1):2-12
pubmed: 21295087
Clin Cancer Res. 2009 Feb 15;15(4):1277-87
pubmed: 19228731
Biomater Sci. 2015 Dec;3(12):1519-33
pubmed: 26280625
ACS Nano. 2014 Jun 24;8(6):6056-65
pubmed: 24824296
Angew Chem Int Ed Engl. 2017 Jan 19;56(4):1059-1063
pubmed: 27981708
Nat Rev Clin Oncol. 2011 Jan;8(1):25-37
pubmed: 20975744
Cell Death Dis. 2013 Oct 10;4:e838
pubmed: 24113172
Autophagy. 2011 Jun;7(6):565-71
pubmed: 21099252
Adv Mater. 2018 Sep;30(38):e1802061
pubmed: 30043416
Theranostics. 2017 May 12;7(7):1990-2002
pubmed: 28638484
Prostate. 2019 Jan;79(1):44-53
pubmed: 30178500
Science. 1999 Dec 24;286(5449):2507-10
pubmed: 10617466
Nature. 2007 Feb 8;445(7128):656-60
pubmed: 17251933
Nat Biotechnol. 2017 Sep 11;35(9):813-815
pubmed: 28898227
Small. 2018 Oct;14(41):e1802565
pubmed: 30230235
Nature. 2000 Nov 16;408(6810):307-10
pubmed: 11099028
EMBO J. 2009 Oct 7;28(19):3015-26
pubmed: 19713938
Cell. 2006 Jul 14;126(1):107-20
pubmed: 16839880
Sci Transl Med. 2015 Nov 18;7(314):314ra183
pubmed: 26582898
Nat Rev Drug Discov. 2008 Dec;7(12):989-1000
pubmed: 19043450
Cancer Res. 2002 Nov 1;62(21):6165-71
pubmed: 12414643
Nano Lett. 2018 Jul 11;18(7):4618-4625
pubmed: 29902013
Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):7779-84
pubmed: 26056316
J Clin Oncol. 2013 Nov 1;31(31):3935-43
pubmed: 24043745
Cancer Res Treat. 2018 Jul;50(3):1023-1038
pubmed: 29121714
Cancer Cell. 2014 Mar 17;25(3):304-17
pubmed: 24651012

Auteurs

Na Kong (N)

Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310058, China.

Wei Tao (W)

Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. wtao@bwh.harvard.edu tianxie@hznu.edu.cn ofarokhzad@bwh.harvard.edu jshi@bwh.harvard.edu.

Xiang Ling (X)

Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Junqing Wang (J)

Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Yuling Xiao (Y)

Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Sanjun Shi (S)

Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Xiaoyuan Ji (X)

Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Department of Cancer Pharmacology, Holistic Integrative Pharmacy Institutes, College of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.

Aram Shajii (A)

Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Silvia Tian Gan (ST)

Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Department of Biology, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada.

Na Yoon Kim (NY)

Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Dan G Duda (DG)

Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

Tian Xie (T)

Department of Cancer Pharmacology, Holistic Integrative Pharmacy Institutes, College of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China. wtao@bwh.harvard.edu tianxie@hznu.edu.cn ofarokhzad@bwh.harvard.edu jshi@bwh.harvard.edu.

Omid C Farokhzad (OC)

Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. wtao@bwh.harvard.edu tianxie@hznu.edu.cn ofarokhzad@bwh.harvard.edu jshi@bwh.harvard.edu.
King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Jinjun Shi (J)

Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. wtao@bwh.harvard.edu tianxie@hznu.edu.cn ofarokhzad@bwh.harvard.edu jshi@bwh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH